acid reflux with tirzepatide Why You Might Tolerate One Weight Loss Drug Better Than Another Is Heartburn a Side Effect

Reviewing existing studies that explore similar drug classes or indirect evidence can provide valuable insights while highlighting areas for future investigation

Tirzepatide, a dual GIP/GLP-1 receptor agonist, has been approved for the management of type 2 diabetes and obesity [14], demonstrating superior efficacy in terms of glycemic control and weight reduction compared with monospecific receptor agonists [15, 16]

Shaking creates foam, introduces air bubbles, and can damage the peptide structure

As a result, patients commonly experience both improved glycaemic control and gradual, sustained weight loss

In paracetamol overdose, a greater proportion of the dose is shunted to the oxidative pathway which results in greater NAPQI formation [13]